LNTH Lantheus Holdings, Inc.

Nasdaq lantheus.com


$ 56.81 $ -0.87 (-1.51 %)    

Monday, 03-Nov-2025 15:59:59 EST
QQQ $ 629.78 $ -3.11 (-0.49 %)
DIA $ 472.70 $ -2.66 (-0.56 %)
SPY $ 681.88 $ -2.29 (-0.33 %)
TLT $ 89.68 $ 0.07 (0.08 %)
GLD $ 366.72 $ 0.05 (0.01 %)
$ 56.82
$ 57.69
$ 54.66 x 97
$ 58.25 x 20
$ 56.02 - $ 58.40
$ 47.25 - $ 118.21
1,422,177
na
3.86B
$ 0.79
$ 14.26
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-06-2025 06-30-2025 10-Q
2 05-07-2025 03-31-2025 10-Q
3 02-26-2025 12-31-2024 10-K
4 11-06-2024 09-30-2024 10-Q
5 07-31-2024 06-30-2024 10-Q
6 05-02-2024 03-31-2024 10-Q
7 02-22-2024 12-31-2023 10-K
8 11-02-2023 09-30-2023 10-Q
9 08-03-2023 06-30-2023 10-Q
10 05-04-2023 03-31-2023 10-Q
11 02-23-2023 12-31-2022 10-K
12 11-03-2022 09-30-2022 10-Q
13 08-04-2022 06-30-2022 10-Q
14 04-29-2022 03-31-2022 10-Q
15 02-24-2022 12-31-2021 10-K
16 11-04-2021 09-30-2021 10-Q
17 07-28-2021 06-30-2021 10-Q
18 05-04-2021 03-31-2021 10-Q
19 02-25-2021 12-31-2020 10-K
20 11-05-2020 09-30-2020 10-Q
21 07-31-2020 06-30-2020 10-Q
22 04-30-2020 03-31-2020 10-Q
23 02-25-2020 12-31-2019 10-K
24 10-31-2019 09-30-2019 10-Q
25 07-25-2019 06-30-2019 10-Q
26 04-30-2019 03-31-2019 10-Q
27 02-20-2019 12-31-2018 10-K
28 10-30-2018 09-30-2018 10-Q
29 08-01-2018 06-30-2018 10-Q
30 05-02-2018 03-31-2018 10-Q
31 02-26-2018 12-31-2017 10-K
32 11-02-2017 09-30-2017 10-Q
33 08-01-2017 06-30-2017 10-Q
34 05-02-2017 03-31-2017 10-Q
35 02-23-2017 12-31-2016 10-K
36 11-01-2016 09-30-2016 10-Q
37 08-04-2016 06-30-2016 10-Q
38 05-03-2016 03-31-2016 10-Q
39 03-02-2016 12-31-2015 10-K
40 11-04-2015 09-30-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 fda-accepts-lantheus-nda-for-mk-6240-investigational-f18-labeled-tau-targeted-pet-imaging-agent-for-detection-of-tau-nft-pathology-in-patients-with-alzheimers-disease-pdufa-date-set-for-august-13-2026

Lantheus Holdings, Inc. ("Lantheus") (NASDAQ:LNTH), the leading radiopharmaceutical-focused company committed to enabli...

 goldman-sachs-downgrades-lantheus-holdings-to-neutral-lowers-price-target-to-77

Goldman Sachs analyst Paul Choi downgrades Lantheus Holdings (NASDAQ:LNTH) from Buy to Neutral and lowers the price target f...

 b-riley-securities-maintains-buy-on-lantheus-holdings-lowers-price-target-to-84

B. Riley Securities analyst Justin Walsh maintains Lantheus Holdings (NASDAQ:LNTH) with a Buy and lowers the price target fr...

 td-cowen-maintains-buy-on-lantheus-holdings-lowers-price-target-to-80

TD Cowen analyst Tara Bancroft maintains Lantheus Holdings (NASDAQ:LNTH) with a Buy and lowers the price target from $95 to ...

 this-union-pacific-analyst-is-no-longer-bullish-here-are-top-5-downgrades-for-tuesday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including...

 truist-securities-downgrades-lantheus-holdings-to-hold-lowers-price-target-to-63

Truist Securities analyst Richard Newitter downgrades Lantheus Holdings (NASDAQ:LNTH) from Buy to Hold and lowers the price ...

 jmp-securities-maintains-market-outperform-on-lantheus-holdings-lowers-price-target-to-73

JMP Securities analyst David Turkaly maintains Lantheus Holdings (NASDAQ:LNTH) with a Market Outperform and lowers the price...

 mizuho-maintains-outperform-on-lantheus-holdings-lowers-price-target-to-70

Mizuho analyst Anthony Petrone maintains Lantheus Holdings (NASDAQ:LNTH) with a Outperform and lowers the price target from ...

 lantheus-holdings-lowers-fy2025-adj-eps-guidance-from-660-670-to-550-570-vs-664-est-lowers-fy2025-sales-guidance-from-1550b-1585b-to-1475b-1510b-vs-1573b-est

Lantheus Holdings (NASDAQ:LNTH) lowers FY2025 Adj EPS guidance from $6.60-$6.70 to $5.50-$5.70 vs $6.64 analyst estimate. Lower...

 lantheus-holdings-q2-adj-eps-157-misses-167-estimate-sales-378045m-miss-389097m-estimate

Lantheus Holdings (NASDAQ:LNTH) reported quarterly earnings of $1.57 per share which missed the analyst consensus estimate of $...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION